Pfizer, BioNTech Announce Completion of Phase 3 Study of COVID-19 Vaccine Candidate Medicine & Technology Nov 19, 2020 Pfizer Inc. and BioNTech SE announced today that their COVID-19 vaccine candidate met all of the primary efficacy endpoints in their study.
Sunscreen Myths Debunked; Expert Warns Against 'Dangerous' Sun Protection Ideas That Only Puts One at Added Risk